Journals / KBB-Forum / 2019 / Cilt: 18 - Sayı: 2

ARE THE NEUTROPHIL/LYMPHOCYTE RATIO (NLR) AND PLATELET/LYMPHOCYTE RATIO (PLR) VALUES USEFUL TO DETERMINE THE PROGNOSIS OF IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS?

ANİ İŞİTME KAYBINDA NLR VE PLR PROGNOZU BELİRLEMEDE İŞE YARAR MI?

Journal
KBB-Forum
Pages
107–113
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, PLR can be used as a marker, albeit a weak one, to determine prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of the present study was to investigate the usefulness of the neutrophil/lymphocyte ratio (NLR) andplatelet/lymphocyte ratio (PLR) as predictive markers for idiopathic sudden sensorineural hearing loss (ISSHNL).Methods: In this retrospective, case-controlled, clinical study, 48 patients who were diagnosed with and treated for the idiopathic suddensensorineural hearing loss were compared to 40 healthy individuals who applied to hospital for routine health checks.
📊
Key Findings & Data:NLR, PLR, White blood cellcount (WBC) and its subgroups were calculated separately for the patient and control groups.Findings: NLR and PLR were significantly higher in the ISSNHL group than in the control group (p 0.05)Conclusion: While the NLR and PLR increases in ISSNHL support the inflammatory theory in ISSNHL, NLR is not an effective markerfor prognosis.
💡
Conclusion & Impact:However, PLR can be used as a marker, albeit a weak one, to determine prognosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of the present study was to investigate the usefulness of the neutrophil/lymphocyte ratio (NLR) andplatelet/lymphocyte ratio (PLR) as predictive markers for idiopathic sudden sensorineural hearing loss (ISSHNL).Methods: In this retrospective, case-controlled, clinical study, 48 patients who were diagnosed with and treated for the idiopathic suddensensorineural hearing loss were compared to 40 healthy individuals who applied to hospital for routine health checks. In addition, the patientswith ISSNHL who responded to the treatment and those who did not were compared and evaluated using statistical methods. The laboratoryanalyses on blood samples from the patients taken before the treatment and from healthy individuals were used. NLR, PLR, White blood cellcount (WBC) and its subgroups were calculated separately for the patient and control groups.Findings: NLR and PLR were significantly higher in the ISSNHL group than in the control group (p 0.05)Conclusion: While the NLR and PLR increases in ISSNHL support the inflammatory theory in ISSNHL, NLR is not an effective markerfor prognosis. However, PLR can be used as a marker, albeit a weak one, to determine prognosis.

Özet

Giriş: Bu çalışmanın amacı nötrofil/lenfosit oranı (NLR) ve platelet/lenfosit (PLR) oranının ani işitme kaybında prediktif bir marker olarak kullanılabilirliğini araştırmaktır. Yöntem: Bu retrospektif, vaka kontrollü, klinik çalışmada kırk sekiz adet ani işitme kaybı tanısı konulmuş ve tedavisi yapılmış ve benzer tedavileri ani işitme kayıplı hasta ile, hastaneye rutin sağlık kontrolleri için başvurmuş sağlıklı 40 birey karşılaştırılmıştır. Aynı zamanda tedaviye cevap veren ve tedaviye cevap vermeyen ani işitme kayıplı hastalar karşılaştırılmış ve istatistiksel yöntemlerle değerlendirilmiştir. Hastaların tedaviden önce alınmış kan örneklerinden elde edilen sonuçlar ile sağlıklı bireylerin laboratuvar değerleri karşılaştırılmıştır. NLR, PLR, Beyaz küre miktarı ve alt grupları hasta grubu için ve kontrol grubu için ayrı ayrı hesaplanmıştır. Bulgular: NLR ve PLR, ani işitme kayıplı hasta grubunda kontrol grubuna göre anlamlı derecede yüksek bulunmuştur (sırasıyla p

🔖

Cite This Article

AKSAKAL, C. (2022). ARE THE NEUTROPHIL/LYMPHOCYTE RATIO (NLR) AND PLATELET/LYMPHOCYTE RATIO (PLR) VALUES USEFUL TO DETERMINE THE PROGNOSIS OF IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS?. KBB-Forum, Cilt: 18 - Sayı: 2, 107–113. https://ajindex.com/articles/573085

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Rauch SD. Idiopathic sudden sensoneurinal hearing loss. N Eng J Med 2008; 359:833-40
  2. Mom T, Gilain L, Avane P. Cochlear ischemia: from fundamental data to clinical hope. Ann Otolaryngol Chir Cervicofac 2008;125:301-8
  3. Wackym PA. Molecular temporal bone pathology: II. Ramsay Hunt syndrome (herpes zoster oticus). Laryngoscope 1997;107:1165-75
  4. Wilson WR, Veltri RW, Laird N, Sprinkle PM. Viral and epidemiologic studies of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg. 1983;91:653-8
  5. Ryan AF, Harris JP, Keithley EM. Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol 2012;122:38-43
  6. Hiramatsu M, Teranishi M, Uchida Y, Nishio N, Suzuki H, Kato K, et al. Polymorphisms in genes involved ininflammatory pathways in patients with sudden sensorineural hearing loss. J Neurogenet 2012;33:387-96
  7. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653-7
  8. Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26:680-681
  9. Huang W, Huang J, Liu Q, Lin, F., He, Z., Zeng, Z, et al. Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy. Clinical Endocrinology.2015; 82: 229-33
  10. Kwon H, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, et al. Clinical significance of preoperative neutrophillymphocyte versus platelet-lympohocyte ratio in patient with operable colorectal cancer. Biomarkers 2012;17:216-22
  11. Siegel LG. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol. Clin N. Am. 1975; 8: 467-73
  12. Ryan AF, Harris JP, Keithley EM. Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta OtoLaryngologica. 2002;548:38-43
  13. Merchant SN, Durand ML, Adams JC. Sudden deafness: is it viral? Journal of Oto-Rhino-Laryngology. 2008; 70: 52-62
  14. Rudack C, Langer C, Stoll W, Rust S, Walter M. Vascular risk factors in sudden hearing loss. Thrombosis and Haemostasis. 2006;95:454-61
  15. Ciccone MM, Cortese F, Pinto M, Di Teo C, Fornarelli F, Gesualdo M, et al. Endothelial function and cardiovascular risk in patients with idiopathic sudden sensorineural hearing loss. Atherosclerosis. 2012;225: 511-16
  16. Ulu S, Ulu MS, Bucak A, Ahsen A, Yucedag F, Aycicek A. Neutrophil-to-lymphocyte ratio as